Kyung Nam Pharm Co Ltd Cash Flow-to-Debt Ratio
Kyung Nam Pharm Co Ltd cash flow-to-debt ratio. Kyung Nam Pharm Co Ltd (053950) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of ₩81.44 Million could theoretically repay 0% of its total liabilities (₩25.73 Billion) in one year. Check earnings quality score of Kyung Nam Pharm Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kyung Nam Pharm Co Ltd (2007–2025)
Cash flow-to-debt ratio of Kyung Nam Pharm Co Ltd from 2007 to 2025. Historical debt coverage capacity for Kyung Nam Pharm Co Ltd across 10 annual periods. Check 053950 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Kyung Nam Pharm Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Kyung Nam Pharm Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Kyung Nam Pharm Co Ltd. For the full cash flow conversion analysis, see Kyung Nam Pharm Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | ₩-1.68 Billion | ₩47.33 Billion | ▼ -199.3% |
| 2024 | 0.04x | ₩1.84 Billion | ₩51.36 Billion | ▲ +296.4% |
| 2023 | 0.01x | ₩693.30 Million | ₩76.78 Billion | ▲ +461.4% |
| 2022 | 0.00x | ₩71.58 Million | ₩44.50 Billion | ▼ -95.7% |
| 2020 | 0.04x | ₩2.62 Billion | ₩69.29 Billion | ▲ +107.8% |
| 2019 | -0.48x | ₩-6.43 Billion | ₩13.27 Billion | ▼ -569.3% |
| 2018 | -0.07x | ₩-1.75 Billion | ₩24.24 Billion | ▼ -142.0% |
| 2016 | 0.17x | ₩4.89 Billion | ₩28.35 Billion | ▲ +2301.3% |
| 2010 | 0.01x | ₩482.65 Million | ₩67.22 Billion | ▲ +52.2% |
| 2007 | 0.00x | ₩148.79 Million | ₩31.55 Billion | — |